Subtherapeutic Dosing
Subtherapeutic Dosing is a dosing strategy in antimicrobial therapy wherein the administered drug concentration falls below the threshold required to effectively inhibit or kill the target pathogen, thereby increasing the risk of selecting for resistant microbial strains.
120
Publications
5.7K
Citations
643
Authors
269
Institutions
Publications per year
2017–2026
35
120
Phase I Clinical Trial Design in Cancer Drug Development
Elizabeth A. Eisenhauer, Peter J. O’Dwyer, Michaele C. Christian et al. · Journal of Clinical Oncology · 2000 · 240 citations
Medicine, Oncology, Pharmacology +14
Sakari Reitamo, Phyllis I. Spuls, B. Sassolas et al. · British Journal of Dermatology · 2001 · 142 citations
1–5 of 120
643
2
h-index
Express Scripts Holding Company (United States), United States
2 publications · 75 citations
2
h-index
2
h-index
The University of Texas MD Anderson Cancer Center, United States
2 publications · 106 citations
2
h-index
2
h-index
1–5 of 643
269

The University of Texas at San Antonio Health Science Center
San Antonio, United States
3 h-index
4 publications
253 citations

Amsterdam UMC Location University of Amsterdam
Amsterdam, The Netherlands
3 h-index
4 publications
229 citations

Johns Hopkins University
Baltimore, United States
3 h-index
6 publications
356 citations

The University of Queensland
Brisbane, Australia
3 h-index
5 publications
163 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
3 h-index
9 publications
966 citations
Harvard University
Cambridge, United States
3 h-index
9 publications
331 citations

University of Mississippi
Oxford, United States
2 h-index
3 publications
59 citations
St. Paul's Hospital
Saskatoon, Canada
2 h-index
8 publications
192 citations
1–8 of 269
Repository · 13 publications · 730 citations
12
h-index
AAC · 5 publications · 166 citations
5
h-index
CPT · 5 publications · 186 citations
5
h-index
BJCP · 4 publications · 123 citations
4
h-index
3 publications · 297 citations
3
h-index
1–5